Company Overview / History

About us

INDEX

Company Overview

Company name: C4U CORPORATION
Establised on: Mar. 15, 2018
CEO: Akimitsu Hirai, President and CEO Top Message > Management/Scientific Advisory Board >
Office: Head Office Techno Alliance Bldg, C-7F, Yamadaoka 2-8, Suita, Osaka 565-0871, Japan Google MAP

Tokyo Lab Mitsui Link-Lab Shinkiba2, Shinkiba 1-17-8, Koto-ku, Tokyo 136-0082, Japan Google MAP

Tokyo Office Shimomeguro 1-3-27, 8F, Meguro-ku, Tokyo 153-0064, Japan Google MAP
Number of Employees: 23 (as of December 31, 2024)
Business: Research and development utilizing novel gene editing technologies Details >
Company Introduction Video: Our company is introduced as one of the companies in Osaka in OPEN! OSAKA. Please take a look.

Head Office

Techno Alliance Bldg, C-7F, Yamadaoka 2-8, Suita,
Osaka 565-0871, Japan
Tokyo Lab

Mitsui Link-Lab Shinkiba2, Shinkiba 1-17-8, Koto-ku,
Tokyo 136-0082, Japan
Tokyo Office

Shimomeguro 1-3-27, 8F, Meguro-ku, Tokyo 153-0064, Japan

2018: Mar.

C4U was established in Toyonaka City, Osaka for the purpose of research and development related to genome editing technology

Aug.

Raised funds from Osaka University Venture Capital
2019: Mar.

Raised funds from Osaka University Venture Capital The fundational patent on the CRISPR-Cas3 system was issued by Japan Patent Office (Patent No. 6480647)

May

Head office relocated to Suita City, Osaka

Oct.

Entered into the exclusive license agreement in regard to the CRISPR-Cas3 technology with Osaka University
2020: Aug.

Akimitu Hirai was appointed as President and CEO
2021: Aug.

Raised a total of 930 million JPY (approximately $8.5 million) in Series A financing
2022: May

Tokyo office opened in Meguro-ku, Tokyo
2023: May

Raised a total of 1.5 billion JPY (approximately $11 million) in Series B financing
2024: Jun.

Tokyo Laboratory opend in Koto-ku, Tokyo